United StatesThe article discusses growing health inequalities across several developed countries, including the UK, US, Germany, Canada, and the Netherlands, highlighting that people in poorer areas experience significantly shorter healthy lifespans compared to those in wealthier regions. These disparities are attributed to both the lingering effects of the pandemic and austerity measures implemented by governments. The piece critiques emerging biotech companies focused on extending human lifespan through costly genetic therapies and cellular rejuvenation, arguing that these innovations primarily serve the wealthy and exacerbate existing social divides. It contrasts this trend with efforts in some regions, like Russia, where urban populations tend to live longer, though systemic issues persist.
Bias read (Left): The article frames the issue of health inequality as a systemic failure exacerbated by government policies and corporate interests, emphasizing the disparity between the wealthy and the poor. While it acknowledges scientific advancements, it criticizes them for serving elite interests rather than全民（
